FDA’s new JAK safety restrictions spell trouble for AbbVie’s Rinvoq, but to what extent?

FDA’s new JAK safety restrictions spell trouble for AbbVie’s Rinvoq, but to what extent?
aliu
Thu, 09/02/2021 – 08:23